Since the aggregate market value of the portfolio exceeds cost, there is no write
down of the individual security whose market value declined to less than one-half
of its cost. Stockholders' equity will be increased (decreased) to the extent that
the excess of market over cost has increased (decreased) over the period. There
is no effect on the income statement.